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Abstract. 
 
The role of integrins in leukocyte apoptosis is
unclear, some studies suggest enhancement, others in-
hibition. We have found that 
 
b
 
2
 
-integrin engagement on
neutrophils can either inhibit or enhance apoptosis de-
pending on the activation state of the integrin and the
presence of proapoptotic stimuli. Both clustering and
activation of 
 
a
 
M
 
b
 
2
 
 delays spontaneous, or unstimulated,
apoptosis, maintains mitochondrial membrane poten-
tial, and prevents cytochrome c release. In contrast, in
the presence of proapoptotic stimuli, such as Fas liga-
tion, TNF
 
a
 
, or UV irradiation, ligation of active 
 
a
 
M
 
b
 
2
 
resulted in enhanced mitochondrial changes and apop-
tosis. Clustering of inactive integrins did not show this
proapoptotic effect and continued to inhibit apoptosis.
This discrepancy was attributed to differential signaling
in response to integrin clustering versus activation.
Clustered, inactive 
 
a
 
M
 
b
 
2
 
 was capable of stimulating the
kinases ERK and Akt. Activated 
 
a
 
M
 
b
 
2
 
 stimulated Akt,
but not ERK. When proapoptotic stimuli were com-
bined with either 
 
a
 
M
 
b
 
2
 
 clustering or activation, Akt ac-
tivity was blocked, allowing integrin activation to en-
hance apoptosis. Clustered, inactive 
 
a
 
M
 
b
 
2
 
 continued to
inhibit stimulated apoptosis due to maintained ERK
activity. Therefore, 
 
b
 
2
 
-integrin engagement can both
delay and enhance apoptosis in the same cell, suggest-
ing that integrins can play a dual role in the apoptotic
progression of leukocytes.
Key words: apoptosis • beta2 integrin • mitochondria
• cytochrome c • neutrophil
 
Introduction
 
Neutrophils have a short lifespan both in vivo and in vitro,
undergoing spontaneous apoptosis with up to 80% death
by 16–20 h of in vitro culture (Savill et al., 1989). This pro-
cess is characterized by cell rounding, nuclear condensa-
tion, internucleosomal DNA fragmentation, and exposure
of phosphatidylserine on the cell surface. Neutrophil apop-
tosis can be accelerated by various stimuli, such as UV irra-
 
diation, Fas, or tumor necrosis factor 
 
a
 
 (TNF
 
a
 
)
 
1
 
 receptor
ligation (Takeda et al., 1993; Liles et al., 1996; Frasch et al.,
1998). The signaling that drives spontaneous and acceler-
ated apoptosis in neutrophils appears to be similar to other
cell types, in that it involves effector caspases (Frasch et al.,
1998), and may be modulated by the Bcl-2 family members
A1, Mcl-1, and Bcl-x
 
L
 
 (Chuang et al., 1998; Moulding et al.,
1998; Weinmann et al., 1999), although a role for mito-
chondria has yet to be established. It is likely that in vivo,
neutrophil apoptosis is important in the homeostatic con-
trol of circulating neutrophil numbers and in the resolution
of acute inflammation. In this latter situation, engulfment
of apoptotic neutrophils by phagocytes both eliminates po-
tentially damaging proinflammatory substances and stimu-
lates the production of antiinflammatory mediators (Fa-
dok et al., 1998). Therefore, an understanding of factors
modulating neutrophil apoptosis is critical to elucidating
the regulation of inflammatory processes.
 
b
 
2
 
-integrins are important molecules for neutrophil func-
tion playing roles in cell activation, homing, and phagocyto-
sis. In constitutively adherent cells, integrins play a critical
role in supporting growth and survival (reviewed in Gian-
cotti and Ruoslahti, 1999). Some evidence exists to support
a similar role for integrins in leukocytes. Antibody cross-
linking of the 
 
a
 
M
 
 integrin chain on neutrophils was shown
to inhibit spontaneous and Fas-mediated apoptosis (Wat-
son et al., 1997a,b) and activated endothelial cells inhibited
neutrophil apoptosis in an ICAM-dependent manner (Gi-
nis and Faller, 1997). In addition, engagement of 
 
b
 
7
 
 inte-
grins was shown to enhance the survival of eosinophils
(Meerschaert et al., 1999). In conflict with this, however,
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are reports that 
 
b
 
2
 
-integrins are involved in enhancing or
stimulating apoptosis. The cell death of thioglycollate-elic-
ited peritoneal neutrophils from 
 
a
 
M
 
 integrin chain deficient
mice was delayed in vitro relative to control mice (Coxon et
al., 1996) and cross-linking of 
 
b
 
2
 
-integrins with antibody, or
adhesion to components of the extracellular matrix has
been shown to enhance TNF
 
a
 
-induced apoptosis (Walzog
et al., 1997; Kettritz et al., 1999). Based on the apparent
contradiction evident in these studies, a role could be pro-
posed for 
 
b
 
2
 
-integrins either in accelerating or delaying ap-
optosis. Therefore, the objective of the current study was to
elucidate the role of 
 
b
 
2
 
-integrins in regulating apoptosis in
controlled in vitro conditions with or without integrin acti-
vation and/or proapoptotic stimuli, and to determine the
signaling pathways involved in these responses.
The 
 
b
 
2
 
-integrin family consists of three 
 
ab
 
 dimers: 
 
a
 
L
 
b
 
2
 
(LFA-1), 
 
a
 
M
 
b
 
2
 
 (Mac-1), or 
 
a
 
X
 
b
 
2
 
 (p150,95). 
 
b
 
2
 
-integrins are
capable of interacting with a diverse array of ligands, but
exist predominantly in an inactive, low affinity state (Dia-
mond and Springer, 1993). However, when activated, they
increase their affinity for multivalent ligands, which leads
to stable cell–cell or cell–matrix adhesion. It is evident that
leukocyte integrins, like their anchorage-dependent coun-
terparts, are capable of activating complex signaling net-
works upon engagement. The initial link between integrins
and downstream signaling events appears to be provided
by several protein tyrosine kinases, including members of
the Src, Syk, and focal adhesion kinase families (Lowell
and Berton, 1999). Recruitment of adapter molecules and
kinases leads to the recruitment and activation of phos-
phatidylinositol-3 kinase (PI-3K; Meng and Lowell, 1998)
and Ras/Raf/mitogen-activated protein kinase (MAPK)
pathways (McGilvray et al., 1998). The adhesion-depen-
dent activation of these pathways is important because
they contribute to optimal cell activation, including in-
creased respiratory burst and cytokine expression (Nathan
et al., 1989; Walzog et al., 1999).
The integrin-mediated downstream signals responsible
for survival in anchorage-dependent cells are similar or
identical to those used by growth factor receptors. Two
kinase pathways that have received considerable atten-
tion are the PI-3K/Akt and extracellular signal-regulated
MAPK (ERK) pathways. Both Akt and ERK are serine/
threonine kinases that are invoked by numerous growth
and survival factors. It may be possible, however, to over-
ride these antiapoptotic stimuli by potential proapoptotic
insults. PI-3K and Akt activity is dramatically inhibited in
fibroblasts exposed to stress stimuli, an effect attributed to
the generation of ceramide (Zundel and Giaccia, 1998). In
addition, insulin-activated PI-3K and ERK are inhibited
by oxidative stress (Hansen et al., 1999; Tirosh et al.,
1999). This type of switch-off mechanism could affect inte-
grin-mediated survival signals and potentially explain the
apparent contradiction in the role of 
 
b
 
2
 
-integrins in leuko-
cyte apoptosis, wherein the survival outcome of integrin
engagement may depend not only on the degree and type
of integrin engagement, but also on the presence or ab-
sence of proapoptotic factors.
Our data demonstrate different cellular responses upon
clustering of inactive 
 
b
 
2
 
-integrins vs. activation of 
 
b
 
2
 
-inte-
grins on neutrophils. We show that either 
 
a
 
M
 
b
 
2 
 
clustering
or activation is differentially capable of activating Akt
and/or MAPK-driven signaling pathways that prevent mi-
 
tochondrial changes and inhibit spontaneous apoptosis.
However, 
 
b
 
2
 
-integrin activation, but not clustering, can en-
hance apoptosis stimulated by Fas ligation, TNF
 
a
 
, or UV
irradiation. This combination of stimuli (integrin activa-
tion and proapoptotic stimuli) shifts the balance in the cell
from an antiapoptotic to a proapoptotic posture by elimi-
nating both Akt activation and mitochondrial protection.
In contrast, 
 
a
 
M
 
b
 
2
 
 clustering, in the absence of activation,
continues to inhibit apoptosis in the presence of proapop-
totic stimuli due to the activation of MAPK-driven signals.
Therefore, we propose a novel model, whereby the state
of integrin activation and the environment in which the
cell resides results in different survival outcomes. Clus-
tered 
 
a
 
M
 
b
 
2
 
, in the absence of integrin activation, is univer-
sally antiapoptotic either during spontaneous or stimu-
lated apoptotic progression. Downstream signals from
activated 
 
b
 
2
 
-integrins are also potentially antiapoptotic,
however, in the presence of death stimuli, these survival
signals are abrogated leading to enhanced cell death.
 
Materials and Methods
 
Antibodies and other Reagents
 
The following mAbs were obtained from commercial sources and were con-
firmed to bind to human PMN by flow cytometry. Anti-
 
a
 
M
 
 2LPM19c, anti-
 
a
 
X
 
 KB90, and anti-HLA-ABC W6/32 were obtained from DAKO. Anti-
 
a
 
M
 
Mo1 was obtained from Coulter Immunotech. Anti-
 
a
 
L
 
 MEM25, anti-
 
a
 
M
 
VIM12, and anti-
 
b
 
2
 
 CLB-LFA1/1 were obtained from Caltag. Anti-
 
b
 
1
 
MAR4, anti-
 
b
 
3
 
 VI-PL2, and anti-CD45 HI30 were obtained from BD
PharMingen. Unless specified otherwise, mAbs were used at a final concen-
tration of 1 
 
m
 
g/ml. All antibodies were tested as dialyzed preparations to
rule out nonspecific effects of commercial solutions. Formyl-methionine-
leucine-phenylalanine (fMLP) was obtained from Sigma-Aldrich and used
at a final concentration of 10
 
2
 
7 
 
M. TNF
 
a
 
 was obtained from R&D and was
used at a final concentration of 1,000 U/ml. Anti-Fas IgM clone CH11 was
obtained from Upstate and used at a concentration of 0.5 or 1 
 
m
 
g/ml to in-
duce apoptosis. Inhibitors of MEK (PD98059, 2
 
9
 
-amino-3
 
9
 
methoxyflavone
and UO126, 1,2-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadi-
ene) and PI-3K (wortmannin and LY294002, 2-(4-morpholinyl)-8-phenyl-
4H-1-benzopyran-4-one) were obtained from Calbiochem.
 
rhICAM-1–coated Bead Preparation
 
Sulfate beads (1 
 
m
 
m; Molecular Probes) were washed in PBS and incu-
bated with 10 
 
m
 
g of soluble recombinant human intracellular adhesion
molecule 1 (rhICAM-1) in 0.9% saline with 20 mM Tris-HCL, pH 7.4, for
30 min at room temperature. We used rhICAM from two different
sources (R&D and Alexa) with identical results. Beads were sonicated for
5 min, and resuspended in HBSS with 10 mg/ml LPS-free human serum al-
bumin (HSA) for 30 min at room temperature. Beads were washed in
HBSS and then resuspended in RPMI plus 1% BSA. This was added to
PMN to give an approximate final concentration of 1 
 
m
 
g/ml rhICAM-1.
Beads coated with HSA alone were used as controls in some experiments
without effect.
 
Neutrophil Isolation
 
Human neutrophils were purified from whole blood as described previ-
ously (Haslett et al., 1985). Neutrophil purity was 
 
.
 
95% with typically
 
,
 
2% eosinophils.
 
Assessment of Apoptosis in Suspension Neutrophils
 
After isolation neutrophils were suspended at 2 
 
3
 
 10
 
6
 
 cells/ml in RPMI sup-
plemented with 1% LPS-free BSA (Sigma-Aldrich, A-1933) and incubated
in conical polypropylene tubes (Sarstedt). Neutrophils, with or without 
 
b
 
2
 
-
integrin reagents, were either allowed to spontaneously apoptose over 10 h
or were exposed to anti-Fas or TNF
 
a
 
 for 4 h. Experiments carried out with
PI-3K and MEK inhibitors used a 30-min preincubation before addition of
stimuli. After the requisite incubation 2 
 
3
 
 10
 
5
 
 cells were diluted and cyto-
centrifuged at 600 rpm for 3 min on to glass slides and stained with a modi- 
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fied Wright-Giemsa stain. Cells were counted as apoptotic if their nuclei
lost segmentation and appeared round and darkly stained. At least 200 cells
were counted per slide in a blinded fashion. The accuracy of morphological
assessment was checked periodically by flow cytometric analysis of hypo-
diploid DNA in propidium iodide stained neutrophils. Apoptotic percent-
ages obtained by these two methods agreed within 5%.
 
Assessment of Apoptosis in Adherent Neutrophils
 
5,000,000 cells were suspended in 1 ml Ca
 
2
 
1
 
/Mg
 
2
 
1
 
-free Krebs-Ringer
phosphate buffer, pH 7.2, containing 0.2% dextrose (KRPD) plus 0.25%
HSA and labeled with a 111-Indium (
 
111
 
In; New England Nuclear) label-
ing mix consisting of KRPD/HSA and 4 
 
3
 
 10
 
2
 
3
 
 M tropolonate. After a 5
min incubation at room temperature, cells were washed with KRPD/HSA
and resuspended at 6 
 
3
 
 10
 
4
 
 cells/ml in RPMI plus 1% BSA. This labeling
procedure had no discernible effect on apoptotic progression. Labeled
neutrophils were added to culture tubes or plated onto 15-mm glass cover-
slips coated overnight with 2.5 mg/ml fibrinogen (Calbiochem). Triplicate
samples for each condition were set up to determine the total amount of
radioactivity present. After a 4–6 h incubation, cells were gently fixed with
dropwise addition of 0.5% glutaraldehyde. Cells were fixed for 30 min at
37
 
8
 
C or overnight at 4
 
8
 
C. Nonadherent cells were removed, washed, and
cytocentrifuged. Cells in suspension were treated identically. Cytospin
preparations and coverslips (adherent cells) were stained with 2 
 
m
 
g/ml
4
 
9
 
,6-diamidino-2-phenylindole (DAPI; Calbiochem) in 50% methanol/
PBS for 20 min. The slides and coverslips were washed gently in PBS and
coverslipped or mounted using 
 
o
 
-phenylenediamine. Cells were examined
for apoptotic morphology by fluorescence microscopy with UV excitation,
with 200–210 cells counted per slide. The overall percentage of apoptotic
cells was determined by multiplying the number of normal and apoptotic
cells by the percentage of nonadherent versus adherent cells measured as
radioactivity present in replicate wells. These adjusted numbers were then
added to determine an overall percentage of normal and apoptotic cells.
 
Determination of Integrin Clustering or Activation
 
For visualization of 
 
a
 
M
 
 clustering, PMN were incubated with the mAbs
2LPM19 or VIM12 at 4 or 37
 
8
 
C for 45 min as above, centrifuged at 1,000 
 
g
 
at 4
 
8
 
C, and resuspended in isotonic 2% paraformaldehyde/sucrose/PBS.
After a 20 min fixation and washing with KRPD/HSA, cells were incu-
bated with 1:200 Cy3-conjugated goat anti–mouse (Jackson ImmunoRe-
search) for 30 min on ice, washed, resuspended in 5–10 
 
m
 
l, mounted onto
glass slides with Gel Mount (Biomeda), and coverslipped. Stained cells
were examined with a 63
 
3
 
 water lens on a Vanox-T Olympus microscope.
For 
 
a
 
M
 
 activation, stimulated PMN were incubated 1 h on ice with 1.5 
 
m
 
g
biotinylated CBRM1/5 (biotinylation was carried out using a commercial
kit (Pierce Chemical Co.) or biotinylated anti-CD45 (BD PharMingen).
Cells were washed and counterstained with 1:50 phycoerythrin-labeled
streptavidin. Cells were analyzed by flow cytometry using FACscalibur
(Becton Dickinson). Total 
 
b
 
2
 
-integrin levels were measured on the same
cells using FITC-labeled anti-CD18 (Caltag).
 
Fab and F(ab
 
9)2 Antibody Preparation
Digestion of the anti-aM clone 2LPM19c and the anti-HLA-ABC clone W6/
32 was accomplished using kits according to manufacturers instructions
(Pierce Chemical Co,). Fab fragments were produced at 378C using an im-
mobilized pepsin slurry. F(ab9)2 fragments were produced at 378C using im-
mobilized Ficin columns. Optimal digestion times were 12 h for Fab and
15 h for F(ab9)2 fragments. Fab and F(ab9)2 fragments were purified with
protein A and fractions collected, assayed for protein content by absor-
bence at 280 nm, pooled, and dialyzed extensively against PBS over a pe-
riod of 24–36 h. The integrity of the fragments was assessed by nonreducing
SDS-PAGE and silver stain, as well as Western blotting with HRP-labeled
anti-mouse antibody. Bands of z110 kD and 50-kD bands were seen corre-
sponding to F(ab9)2 and Fab fragments, respectively. Neutrophils were
stained with antibody fragments to confirm binding, and in addition,
2LPM19c fragments were tested for their ability to block fMLP-induced ad-
hesion to confirm functionality of these fragments. All 2LPM19c fragments
used in this study were able to inhibit adhesion as well as whole antibody. 
ERK Immunoprecipitation and Kinase Assay
Lysates from isolated PMN, incubated with the appropriate stimulus at
378C, were assayed for ERK activity using a enzyme activity reagent kit
(Upstate) with slight modification of the provided protocol. After stimula-
tion, 7.5 3 106 cells were centrifuged at 48C and lysed with ice cold RIPA
buffer (supplemented with 15 mg/ml leupeptin and aprotinin, 1 mM PMSF
and 0.2 mM sodium orthovanadate). Lysates were centrifuged at 12,000
rpm at 48C for 10 min. Supernatants were transferred to protein A–Seph-
arose (Zymed) beads containing 1 mg of rabbit anti-ERK2 antibody
(Santa Cruz) and incubated for 2 h at 48C with rotation. After incubation,
beads were washed twice with cold lysis buffer and once with assay buffer
(Upstate). Beads were resuspended in 50 ml assay buffer containing my-
elin basic protein, inhibitor cocktail, 1 mCi g[32P]ATP (Amersham Phar-
macia) and Mg/ATP cocktail. Beads were incubated for 10 min at 308C
with agitation. A portion of the reaction mix was transferred to P81 phos-
phocellulose paper, washed three times with 0.75% phosphoric acid, and
analyzed by liquid scintillation counting.
Akt Immunoprecipitation and Kinase Assay
As with the ERK assays, Akt activity was measured using a enzyme activ-
ity kit (Upstate) with some modification of the provided protocol. PMN
were lysed as in ERK assays. Supernatants were immunoprecipitated with
protein–G Sepharose (Zymed) and 1 mg rabbit anti-Akt antibody (Santa
Cruz). A purified rabbit polyclonal antibody to the unrelated kinase Rsk1
(Santa Cruz) was used as a control for specific immunoprecipitation of
both Akt and ERK activity. Beads were incubated for 2 h at 48C with rota-
tion. Beads were washed as above and resuspended in 40 ml assay buffer
containing substrate peptide (RPRAATF), protein kinase A inhibitor, 1
mCi  g[32P]ATP (1 mCi; Amersham Pharamcia), and Mg/ATP cocktail.
Samples were incubated for 10 min at 308C with agitation, centrifuged,
and supernatants transferred to 20 ml 40% TCA, mixed, and incubated for
5 min at room temperature. A portion of the reaction mix was transferred
to P81 phosphocellulose paper, washed as above and analyzed by liquid
scintillation counting. Optimal activation times for Akt and ERK were de-
termined for all appropriate stimuli.
Staining of Mitochondria
After stimulation, PMN were incubated with 10 mM JC-1 (Molecular
Probes) at 378C for 10 min, centrifuged, resuspended in cold PBS, and an-
alyzed by flow cytometry with an excitation wavelength of 480 nm and
585/42-nm emission filter. Decreases in mean fluorescence intensity (FL-2)
correspond to a loss of fluorescent JC-1 J aggregates in the mitochondria
that occurs upon decreased mitochondrial membrane potential (Cossa-
rizza et al., 1993). For fluorescence microscopy, cells were stained as
above, washed, resuspended, and gel mounted on to glass slides.
MAB1273 (Chemicon) staining was carried out in permeabilized cells
(0.1% Tween20 in PBS/BSA) with MAB1273 for 30 min at 378C, followed
by washing (twice with PBS/BSA) and detection with 1:1,000 Cy3-conju-
gated F(ab9)2 anti-mouse IgG (Jackson ImmunoResearch). Cells were
washed, mounted, and visualized as above.
Cytochrome c (CytC) Immunostaining
Human PMN were incubated with stimuli for 1 or 1.5 h and CytC staining
was performed as described elsewhere (Kennedy et al., 1999). The speci-
ficity of CytC localization was determined using mitotracker red CXC
(Mito trk; Molecular Probes) as a costain. After fixation and CytC stain-
ing, cells were incubated with 1 mM Mito trk for 10 min, washed (twice)
and mounted. Stained cells were examined as above using the FITC
(CytC) and Cy3 filters (Mito trk).
Data Analysis
Averages and SD values were calculated from at least three experiments.
Statistical analysis was carried out using the JMP statistical program (SAS
Institute, Cary, NC). The Tukey-Kramer and Dunnett’s parametrical tests
were used for single and multiple comparisons, respectively. Parametric
tests were determined to be appropriate based on apparent normal distri-
bution and equal variances (O’Brein test) of apoptosis data.
Results
Clustering or Activation of b2-Integrins Can Inhibit 
Neutrophil Apoptosis
Clustering of integrins in cell membranes contributes to
the activation of survival signals (Giancotti and Ruoslahti,
1999). Therefore, our initial objective in this study was toThe Journal of Cell Biology, Volume 151, 2000 1308
Figure 1. Inhibition of spontaneous neutrophil
apoptosis by blocking or activating antibodies to
b2-integrins. (A) Inhibition of apoptosis was spe-
cific for antibodies to aL,  aM and b2-integrin
chains. Neutrophils (2 3 106 cells/ml) were incu-
bated at 378C in polypropylene tubes with 1 mg/
ml of antibody and apoptosis assessed by cellular
morphology at 10 h. The data represent mean
percent inhibition of apoptosis 6 SD of four ex-
periments. The average control apoptosis at 10 h
was 39 6 11% and the means of all antibody
treatments were compared with this value using
the multiple comparison Dunnett’s Test (*P ,
0.05). (B) F(ab9)2 fragments, but not monovalent
Fab, of anti-aM mAb 2LPM19c inhibited apop-
tosis. Mean percent inhibition 6 SD of three
experiments. (C) Inhibition time course of
blocking anti-aM clone (2LPM19c) or activating
anti-aM clone (VIM12). Anti-CD45 (HI30) is
shown as a negative control. Neutrophils were
treated with 1 mg/ml of antibody and apoptosis
determined at 2, 10, and 20 h. Graph is represen-
tative of five experiments.Whitlock et al. aMb2 Regulation of Apoptosis 1309
determine if aMb2 clustering on neutrophils by direct en-
gagement could modulate apoptosis. The experiments
were performed under defined conditions with cells incu-
bated in suspension, thus minimizing surface interaction.
In this circumstance, integrin engagement with anti-
bodies to either the aM or b2 subunits delayed the apopto-
sis of human neutrophils (Fig. 1 A). Anti-aM antibodies
(2LPM19c, VIM12, and Mo1), an anti-b2 antibody, and an
anti-aL antibody, all inhibited neutrophil apoptosis by 30–
60% at 10 h. In contrast, antibody to ax, a component of
the b2-integrin p150,95, was largely ineffective, as were an-
tibodies to b1 and b3 integrin chains. Antibodies to the
nonintegrin surface molecules HLA and CD45 were also
ineffective. A F(ab9)2 fragment of 2LPM19c (hereafter re-
ferred to as 19c) was very effective at inhibiting neutrophil
apoptosis indicating lack of FcgR involvement (Fig. 1 B).
A monovalent Fab fragment of the same antibody had no
effect, demonstrating that the apoptosis inhibition seen
with 19c was not due to blocking cell–cell proapoptotic ad-
hesive signals (19c Fab and F(ab9)2 were equally efficient
at inhibiting adhesion), but rather a direct result of biva-
lent antibody engagement and b2-integrin clustering or
cross-linking (Fig. 1 B). b2-integrin–mediated survival was
not limited to antibody engagement as incubation of neu-
trophils with rhICAM-1, a natural ligand for b2-integrins,
immobilized on 1 mm beads also suppressed apoptosis
(Fig. 2). This suppression was due to ICAM-aMb2 interac-
tions since blocking anti-aM Fab (itself noninhibitory)
completely reversed this suppression (Fig. 2). Like anti-
body-mediated inhibition, ICAM-induced inhibition also
required multivalent binding and clustering since soluble
rhICAM-1, which exists largely in monomeric form (Reilly
et al., 1995), had no effect on apoptosis (data not shown).
The inhibitory effect of aMb2 clustering was still evident
late in culture (20 h), suggesting the induction of long-term
survival signals in neutrophils (Fig. 1 C).
Since b2-integrins exist largely in an inactive state and
do not exhibit high affinity for ligands unless activated
(Diamond and Springer, 1993), it was important to distin-
guish between the effects of aMb2 clustering and activation
on apoptosis. In contrast to 19c, which blocks aMb2-medi-
ated adhesion by interacting with the major ligand binding
domain (I-domain) of aM (Diamond et al., 1993), VIM12
is an outside-in activator of aMb2-dependent adhesion
(Stöckl et al., 1995). Like VIM12, Mn21 addition can also
activate b2-integrins via outside-in mechanisms and stimu-
late leukocyte adhesion and aggregation (Altieri, 1991;
Lynman et al., 1998). As demonstrated in Fig. 2, both
VIM12 and Mn21 were effective in suppressing apoptosis
from 40–60%. Importantly, VIM12 and Mn21 inhibition of
apoptosis was reversed by blocking anti-aM Fab, but not a
control Fab, suggesting dependence on ligand binding by
aMb2 in these suspension cultures.
Before further elucidating the mechanism of apoptosis
inhibition via clustered or activated integrins, it was impor-
tant to confirm aM clustering and/or activation in our cul-
ture system. Both 19c, as well as the activating antibody
VIM12, were capable of punctate membrane clustering of
aMb2 during 378C incubation with antibodies, whereas a
ring-like, uniform distribution of aMb2 was seen at 48C (Fig.
3 A). Incubation of cells at 378C in the presence of rhICAM
beads and Mn21 also resulted in aMb2 clustering (data not
Figure 2. Inhibition of neutrophil apoptosis after
b2-integrin activation or clustering is reversed by
anti-aM Fab. b2-integrins were either activated
with Mn21, activating antibody (VIM12), or
fMLP or clustered with immobilized rhICAM. In
all cases blockade of apoptosis was reversed by a
10-min preincubation with 1 mg 2LPM19c Fab.
Preincubation with anti-HLA Fab (clone W6/32)
had no effect. Data represents mean percent ap-
optosis 6 SD of three experiments.The Journal of Cell Biology, Volume 151, 2000 1310
shown). To determine the activation state of aM, we used
the activation epitope antibody CBRM 1/5 kindly supplied
by Dr. T. Springer (Harvard Medical School, Boston, MA;
Diamond and Springer, 1993). As expected, VIM12 incuba-
tion resulted in an increase in CBRM 1/5 binding with no
increase in a control surface marker (CD45) and only a
slight increase in total b2-integrin levels (FITC-labeled
anti-CD18; Fig. 3 B, top). Mn21 exposure also resulted in a
consistent increase in CBRM 1/5 binding (data not shown).
Unfortunately, the activation state of aMb2 in the presence
of 19c could not be determined due to steric hindrance be-
tween this antibody and CBRM1/5, as seen by the complete
abrogation of fMLP-stimulated upregulation of CBRM1/5
binding (Fig. 3 D). However, 19c does not appear to acti-
Figure 3. Clustering and activa-
tion of aMb2 integrin on neutro-
phils. (A) Activating (VIM12)
and blocking (2LPM19c) anti-
bodies to aM are capable of inte-
grin clustering at 378C, but not
at 48C. Fresh neutrophils were
incubated with 2 mg/ml of either
VIM12 or 2LPM19c at 4 or 378C
for 45 min and stained as in Ma-
terials and Methods. Figures are
representative of four experi-
ments. Bar, 5 mm. (B) VIM12
treatment, but not rhICAM-1
beads, induced aM-integrin acti-
vation as measured by mAb
CBRM 1/5 binding. Neutrophils
were treated as above with ei-
ther VIM12 or rhICAM beads
(1 mg of total ICAM) and were
then stained as in Materials and
Methods. To assess total b2-inte-
grin levels, cells were stained
with FITC–anti-CD18. Histo-
grams are representative of six
experiments. (C and D) Block-
ing of fMLP-stimulated
CBRM1/5 binding by 2LPM19c
(D), but not rhICAM-1 beads
(C). Neutrophils were treated
with 2LPM19c or rhICAM-1
beads as above, followed by a 5
min incubation with fMLP and
staining with biotinylated
CBRM1/5. Histograms are rep-
resentative of four experiments.Whitlock et al. aMb2 Regulation of Apoptosis 1311
vate aMb2, insofar as it does not stimulate cell adhesion or
aggregation (Diamond et al., 1993; data not shown). In ad-
dition, cells treated with rhICAM beads did not show in-
creased CBRM1/5 binding or increased total b2-integrin
levels (Fig. 3 B, bottom) indicating that rhICAM beads also
were not directly activating aMb2. This apparent lack of ac-
tivation was not due to a masking of aMb2 activation, like
that seen with 19c, since fMLP-stimulated neutrophils coin-
cubated with rhICAM beads and CBRM1/5 showed unaf-
fected upregulation of CBRM1/5 epitope expression (Fig. 3
C). The lack of b2-integrin activation by rhICAM is further
supported by the observation that the binding of rhICAM
beads did not increase significantly over time (up to 4 h)
suggesting that the binding of rhICAM did not lead to any
measurable increase in adhesion (data not shown). Overall,
our data support that 19c and rhICAM beads elicit b2-inte-
grin clustering without leading to any substantial activa-
tion; whereas VIM12 and Mn21 are capable of activating
b2-integrins leading to increased neutrophil adhesiveness.
Differential Activation of PI-3 Kinase and MAPK 
(ERK) Pathways after aMb2 Clustering or Activation
Studies in adherent cells have implicated PI-3K and ERK
pathways in mediating integrin survival signaling (Gian-
cotti and Ruoslahti, 1999). As shown in Fig. 4 A, inhibitors
of the ERK activator MEK (PD98059), or PI-3K (wort-
mannin) were each able to reverse the antiapoptotic effect
of aMb2 clustering with either 19c F(ab9)2 or rhICAM-1
coated beads (Fig. 4 A). This pattern of reversal was also
seen with the MEK inhibitor UO126 and the PI-3K inhibi-
tor LY294002 (data not shown) indicating likely specificity
for MEK and PI-3K. This nearly complete reversal of inte-
grin clustering-mediated survival suggested major involve-
ment of PI-3K and MEK driven pathways in the inhibition
of apoptosis. In contrast, aMb2 activation-mediated inhibi-
tion with either VIM12 or Mn21 was reversed by wortman-
nin or LY294002, but was unaffected by the MEK inhibi-
tors (Fig. 4; LY294002 and UO126, data not shown),
indicating involvement of PI-3K pathways only. Thus, a
clear difference between signals induced by b2-integrin ac-
tivation and clustering is suggested.
The chemotactic peptide fMLP was included in these
experiments because of its known, characterized, ability to
activate b2-integrins in neutrophils (Fig. 3 B; Jones et al.,
1998). It is clear from Fig. 2 that fMLP, like VIM12 and
Mn21, inhibits apoptosis via aMb2-dependent mechanisms.
However, fMLP activates via signaling from the fMLP re-
ceptor to the integrin (inside-out activation). Unlike out-
side-in activation with VIM12 and Mn21, suppression by
fMLP was reversed by both wortmannin and PD98059
(Fig. 4 A). This is consistent with the known ability of
Figure 4. Inhibition of apoptosis by b2-integrin activation in-
volves PI-3K/Akt, whereas inhibition by integrin clustering in-
volves both PI-3K/Akt and MAPK pathways. (A) Neutrophils
were preincubated for 10 min with either 30 mM PD98059 or 100
nM wortmannin before the addition of stimuli that activate
(MnCl2, VIM12, or fMLP) or cluster (2LPM19c F(ab9)2 or immobilized rhICAM-1) b2-integrins. Concentrations of PD98059 and wort-
mannin used were chosen based on values reported elsewhere (Alessi et al., 1995; Arcaro and Wynman, 1993) and dose response curves
for the reversal of apoptosis inhibition. Cells were incubated for 10 h and apoptosis assessed by morphology. Bars represent mean per-
cent inhibition of apoptosis 6 SD of three experiments. (B) Activation of Akt by aM integrin clustering (2LPM19c or rhICAM-1 beads)
or aM activation (VIM12 or MnCl). Neutrophils were incubated with each stimulus without or with 100 nM wortmannin for 20 min. (C)
Activation of ERK by aM integrin clustering (2LPM19c), but not aM activation (VIM12). Cells were treated as in A, except without or
with 30 mM PD 98059. Akt and ERK activity was measured as the incorporation of 32P above untreated cells (cpm 6 SD; n 5 3).The Journal of Cell Biology, Volume 151, 2000 1312
fMLP to activate MEK driven pathways in neutrophils
(Worthen et al., 1994). Therefore, the reversal of fMLP-
mediated neutrophil survival by blocking MEK/ERK-
driven pathways could be due to a blockade in a pathway
leading to integrin activation rather than, or in addition to,
inhibition of a survival pathway originating from aMb2.
Due to the possible difference between the survival path-
ways elicited by the clustering of inactive integrins and inte-
grin activation, we postulated differences in downstream ki-
nase activation. Akt and ERK are serine/threonine kinases
that are downstream of PI-3K and MEK1, respectively, and
are known to be involved in survival signaling by maintaining
an antiapoptotic balance among Bcl-2 family members
(Datta et al., 1999; Scheid et al., 1999; Townsend et al., 1999).
Clustering of aMb2 by 19c (intact antibody or F(ab9)2), or
rhICAM beads, activated both Akt and ERK as measured
by in vitro kinase assays with immunoprecipitated enzymes at
20 min of stimulation (Fig. 4, B and C). As expected, the acti-
vation of Akt was inhibited by wortmannin and ERK by
PD98059. Fab fragments of 19c were inactive (data not
shown), thus correlating with their lack of effect on apoptosis.
By contrast, VIM12 and Mn21 stimulated Akt activity, with-
out activating ERK (Fig. 4, B and C). These observations,
combined with the inhibitor experiments (Fig. 4 A), provide
Figure 5. Both b2-integrin activation and clustering maintains mitochondria membrane potential and prevents cytochrome c release. (A)
Identification and localization of mitochondria in neutrophils. Fresh cells were stained with either a mitochondria marker MAB1273 (1 mg)
or the mitochondria permeable dye JC-1 (10 mM), and analyzed by fluorescent microscopy. Two cells stained with each reagent are shown.
Bar, 5 mm. (B and C) aMb2 integrin-mediated maintenance of mitochondria membrane potential. Fresh neutrophils (0 h), or neutrophils in-
cubated for 4 h without or with VIM12 or 2LPM19c, were stained with 10 mM JC-1 and analyzed by flow cytometry. B shows representa-
tive histograms from 3 individual experiments. (C) Bars represent the mean percent increase in JC-1 fluorescence over cells at 4 h 6 SD
(n 5 3). (D) aMb2 integrin-mediated prevention of CytC release. Neutrophils were incubated for 1.5 h as above, permeabilized, and stained
with anti-CytC antibody as in Kennedy et al. (1999). Mitochondria specific staining of anti-CytC was confirmed in fresh neutrophils by co-
staining with mitotracker red (Mito trk) with colocalization verified by overlaid green/red fluorescence (CytC/Mito trk). Bar, 5 mm.Whitlock et al. aMb2 Regulation of Apoptosis 1313
good evidence for a difference in the antiapoptotic signaling
generated via aMb2 clustering versus activation.
While both aMb2 clustering and activation stimulated
Akt activity, the kinetics was somewhat different. Cluster-
ing-induced Akt activity appeared at 10 min, peaked at
15–20 min, and was undetectable by 30 min. After integrin
activation, however, Akt activation continued to increase
over the entire time course (30 min).
aMb2-mediated Protection Against
Mitochondrial Damage
One of the hallmarks of apoptotic changes is the loss of
mitochondrial membrane potential and release of CytC.
Although neutrophils do not contain large numbers of mi-
tochondria (Edwards, 1994), it seemed reasonable to hy-
pothesize a similar response in these cells. The cationic, li-
pophilic dye JC-1 forms fluorescent J aggregates in the
mitochondria of healthy, nonapoptotic cells. As mitochon-
drial membrane potential decreases during apoptosis, the
J aggregate formation (fluorescence) also decreases (Cos-
sarizza et al., 1993). Intracellular localization of JC-1 to
mitochondria in neutrophils was verified by comparing lo-
calization of JC-1 staining with the staining pattern of a
mitochondrial marker antibody (MAB1273; Fig. 5 A).
(Costaining with JC-1 and MAB1273 could not be per-
formed on the same cell because of the broad emission
spectrum of JC-1 and filter limitations.) As expected, JC-1
fluorescence decreased during spontaneous apoptosis
(compare control histograms at 0 and 4 h) and this was
blocked by both aMb2 clustering and activation (Fig. 5 B).
This block in fluorescence decrease is shown graphically in
Fig. 5 C, where the data are shown as percent fluorescence
increase over control cells at 4 h. Both 19c and VIM12
yield an z50% increase in JC-1 fluorescence over that of
control (4 h) cells indicating a maintenance of mitochon-
drial membrane potential. In addition, we examined the
presence of CytC in neutrophils via immunofluorescence
to confirm a possible correlation with the loss of mito-
chondrial potential. As seen in the top of Fig. 5 D, CytC
could be detected in fresh neutrophils, and costaining with
a mitochondrial dye (MitoTracker Red) revealed a cyto-
plasmic punctate pattern (localization that agrees well
with JC-1- and MAB1273 staining; Fig. 5 A). The amount
of CytC detected after 1.5 h in culture was significantly de-
creased (Fig. 5 D, bottom, Control), indicating a spontane-
ous release of CytC from the mitochondria. However,
integrin clustering or activation with 19c or VIM12 pre-
vented the apparent release of CytC. Combined, these
data provide good evidence that mitochondrial protection
is a downstream mechanism for integrin-mediated inhibi-
tion of spontaneous neutrophil apoptosis.
The Antiapoptotic Effect of b2-integrin Activation Is 
Switched to Apoptosis Enhancement and Mitochondrial 
Damage in the Presence of Death Stimuli
While the experiments described above show that aMb2
engagement, either by clustering, or by activation/ligand
interaction, inhibit neutrophil apoptosis, several reports
suggest that b2-integrins may also be involved in enhanc-
ing apoptosis (Coxon et al., 1996; Walzog et al., 1997;
Kettritz et al., 1999). However, these studies were per-
formed with inflammatory neutrophils (Coxon et al., 1996)
or with the addition of TNFa (Walzog et al., 1997; Kettritz
et al., 1999). This raises the possibility that aMb2 engage-
ment could have differential effects on survival, depending
on the integrin activation state and the presence or ab-
sence of other stimuli. The data shown in Fig. 6 A support
this concept. The activating antibody, VIM12, as well as
Mn21 enhanced apoptosis induced by anti-Fas, TNFa, or
UV irradiation. By contrast, clustering of aMb2 with 19c or
rhICAM-1 beads before the addition of anti-Fas, TNFa,
or UV irradiation continued to suppress apoptosis.
This observation suggested that we may see an enhance-
ment of induced mitochondrial damage in the presence of
integrin activation. Fig. 6 B shows JC-1 fluorescence as
measured in neutrophils incubated for 4 h with no stimulus
or with anti-Fas in the presence and absence of either aMb2
clustering (19c) or activation (VIM12). Treatment with anti-
Fas resulted in a decrease in JC-1 fluorescence compared
with control neutrophils (Fig. 6, B and C). The combination
of anti-Fas plus VIM12-induced aMb2 activation dramati-
cally enhanced this decrease. In contrast, aMb2 clustering
with 19c showed no change in anti-Fas induced mitochon-
drial changes, even though 19c suppresses anti-Fas–induced
apoptosis. TNFa and UV-induced loss of mitochondrial
membrane potential was also increased by VIM12 (data not
shown), correlating with the enhancement of TNFa and
UV-induced apoptosis. In addition, mitochondrial CytC re-
lease was also enhanced in the combined presence of anti-
Fas and VIM12. Fig. 6 D shows CytC in control (1 h) and
anti-Fas treated neutrophils. The CytC immunostaining
correlates with JC-1 fluorescence and is decreased in the
presence of anti-Fas. An even greater loss of CytC staining
is seen with the anti-Fas/VIM12 combination with no
change seen with the anti-Fas/19c combination.
The data contained in Fig. 6 is indicative of a major dif-
ference between the functional outcome of either b2-inte-
grin clustering or b2-integrin activation and strongly sug-
gest that activated aMb2 can serve a dual role, preventing
mitochondrial damage and cell death in one situation, but
aiding proapoptotic stimuli by enhancing mitochondrial
damage and cell death in another.
Proapoptotic Stimuli Abrogate aMb2-induced
Akt Activation
The enhancement of stimulus-induced neutrophil apopto-
sis seen in the presence of aMb2 activation suggested that
the integrin-activated survival signals might be disrupted.
To investigate this, b2-integrin–mediated Akt activation,
common to clustering and activation, was examined in the
absence or presence of anti-Fas IgM (Fig. 7). VIM12 and
Mn21 stimulated Akt activity was entirely inhibited in the
presence of Fas ligation, as was 19c and rhICAM bead
stimulated Akt activity. Therefore, the switch from inte-
grin-mediated survival and mitochondrial protection to in-
tegrin-mediated death enhancement may result from an
active downregulation of Akt survival mechanisms.
Surprisingly, anti-Fas alone activated Akt to a compara-
ble degree to that of aMb2 clustering or activation (Fig. 7).
It was the combination of these stimuli that lowered Akt
activity to control levels. This strongly suggests that signals
originating from Fas and aMb2 can synergize to prevent
the activation of Akt.The Journal of Cell Biology, Volume 151, 2000 1314
aMb2 Clustering Continues to Inhibit Stimulated 
Apoptosis in the Absence of Akt Activation Due to 
MAPK Activation
As noted above, both aMb2 clustering and aMb2 activation
can synergize with Fas to eliminate Akt activation. However,
unlike b2-integrin activation, clustering of b2-integrins contin-
ued to inhibit stimulated apoptosis in the absence of mito-
chondrial protection (Fig. 6) or Akt activity (Fig. 7). As indi-
cated in Fig. 4, clustering of aMb2 via 19c or rhICAM beads
activated ERK in addition to Akt. Thus, aMb2 clustering may
still be capable of activating ERK in the presence of Fas liga-
tion. We tested this hypothesis and found that ERK activity
was unaffected by coincubation with anti-Fas (Fig. 8 A). In
conjunction with these experiments we found that the sus-
tained inhibitory effect of 19c or rhICAM beads on anti-Fas–
induced apoptosis could be reversed by the MEK inhibitor
PD98059 (Fig. 8 B). This observation suggests that ERK can
compensate for the loss of PI-3K–dependent Akt activity in
neutrophils with clustered, inactive aMb2 and inhibit stimu-
lated cell death in a manner that appears to be independent
of mitochondrial protection (Fig. 6, B, C, and D).
Figure 6. Stimulus-induced apoptosis and mitochondrial
changes were enhanced by aMb2 activation. (A) Activated
aMb2, but not clustered, inactivated aMb2, enhanced apoptosis
induced by TNF a, anti-Fas IgM, or UV irradiation. VIM12
and 2LPM19c were added simultaneously with anti-Fas IgM
or TNF a and allowed to incubate for 4 h. UV treated cells
were allowed to incubate with antibodies for 1 h before a 5 min
UV exposure; cells were then incubated for 2 h. Bars represent the mean percent change in apoptosis compared with untreated cells 6 SD
(n 5 3). Average control apoptosis levels were 46% for anti-Fas, 27% for TNFa, and 49% for UV-treated cells. (B and C) aMb2 activation in
combination with anti-Fas resulted in increased reduction of mitochondria membrane potential. Cells were incubated for 4 h with anti-Fas
IgM without or with antibodies. JC-1 staining and analysis was carried out as in Fig. 5. (B) Histograms are representative of three experi-
ments. (C) Bars represent the mean percent decrease in FL2 compared with 4 h cells 6 SD (n 5 3). (D) aMb2 activation in combination with
anti-Fas resulted in greater CytC release from mitochondria. Cells were treated and stained for CytC as above. The intensity of these images
was increased relative to Fig. 5 D to illustrate loss of CytC staining upon incubation with anti-Fas and anti-Fas plus VIM12. Bar, 10 mm.Whitlock et al. aMb2 Regulation of Apoptosis 1315
Adherence of Neutrophils to Fibrinogen Inhibits 
Apoptosis in a Manner Identical to
b2-integrin Clustering
All of the experiments to this point were carried out on
neutrophils in suspension. The fact that b2-integrins are
the primary adhesion molecules on neutrophils and can
mediate adhesion to a wide variety of ligands raised the
likelihood that b2-integrin mediated surface engagement
would also modulate neutrophil apoptosis.
To clearly determine surface effects on apoptosis, a spe-
cial adhesion system was established. The experiments
were performed on fibrinogen-coated glass coverslips us-
ing a very low cell number (6 3 104 cells/ml compared with
2 3 106 cells/ml in suspension incubations) to maximize
cell-surface interaction and minimize cell–cell interaction.
At more normal cell concentrations, and as in most studies
of these phenomena (Ginis and Faller, 1997; Kettritz et al.,
1999), only a portion of the neutrophils could conceivably
adhere to the available surface, many would adhere to
each other. A further problem in these systems is the like-
lihood that when the neutrophils become apoptotic, their
surface adhesion is lost. To assure assay of the entire neu-
trophil population, 111In-tagged cells were used and cells
that lifted off the surface, as well as those that remained
adherent, were included in direct assessment of nuclear
condensation by the nuclear dye DAPI.
Using these methods, neutrophils on fibrinogen were
shown to exhibit decreased spontaneous apoptosis com-
pared with those (at an equal cell concentration) incubated
in suspension (Fig. 9). As expected, the surface mediated-
survival was reversed by wortmannin and PD98059 in a
fashion identical to the aMb2 clustering agents 19c and
rhICAM-1 beads. Since neutrophils interact with ligands
like fibrinogen with high affinity upon activation, it was im-
portant to examine this phenomenon in the presence of
fMLP. Like unstimulated neutrophils, fMLP-stimulated
neutrophils exhibited significant increased survival on fi-
brinogen, an effect that was greater than unstimulated cells
and was significantly reversed by wortmannin and PD98059
(Fig. 9). This agrees with the inhibitory effects of fMLP in
suspension and the ability of fMLP to directly activate MAP
kinase pathways. The increase in inhibition seen in the pres-
ence of fMLP plus fibrinogen was also seen in combination
with rhICAM beads (data not shown). Therefore, these data
further support a role for b2-integrin engagement in the in-
hibition of neutrophil apoptosis and suggest that the interac-
tion of both inactive and active b2-integrins with different
surface bound natural ligands, in the absence of proapop-
totic signals, are capable of significantly inhibiting apoptosis.
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Discussion
We conclude that a significant function for b2-integrins on
neutrophils is the modulation of cell survival. As outlined
in the introduction, some studies have implicated integrins
in either promoting neutrophil survival or enhancing ap-
optosis, depending on the type of integrin engagement and/
or the presence of proinflammatory or proapoptotic stim-
uli. The current study explains these apparent contradic-
tions by establishing a dual role for b2-integrins in cell sur-
vival and provides a potential signaling explanation for
this observation. This dual role is a result of a clear differ-
ence between the functional outcome and signals induced
by b2-integrin clustering versus activation (Fig. 10).
The engagement of inactive aMb2 with 19c, a mAb that in-
teracts at or near the I-domain of aM (Fig. 1), was capable of
inhibiting the spontaneous apoptosis of human neutrophils
via activation of ERK and Akt, followed by mitochondrial
protection. We believe that this requires some degree of aMb2
clustering since bivalent molecules (whole or F(ab9)2) were
required to elicit this effect. In addition, VIM12, an antibody
capable of activating aMb2 (Stöckl et al., 1995), was also capa-
ble of inhibiting spontaneous apoptosis, protecting mitochon-
dria and activating Akt, but not ERK. Therefore, while defi-
nite differences exist in the signaling response of neutrophils
to either b2-integrin clustering or activation (Figs. 4 and 6),
both are capable of inhibiting spontaneous apoptosis (Fig. 2).
Like the mAb 19c, the natural aMb2 ligands ICAM and
fibrinogen, when immobilized, were capable of inhibiting
spontaneous neutrophil apoptosis (Figs. 2 and 9), a phe-
nomenon that we attribute to integrin clustering. We can
detect a small, consistent percentage of resting neutrophils
bound to ICAM-1 beads and fibrinogen-coated coverslips
in the absence of measurable CBRM1/5 binding (data not
shown), suggesting that unactivated aMb2 is capable of
binding immobilized ligands to some degree. A low per-
centage of adhering cells is not surprising given the low af-
finity of unactivated aMb2 for ligands like ICAM. How-
ever, a recent report indicates that low affinity aLb2/ICAM
interactions on resting T cells are capable of initiating clus-
tering of inactive aLb2 on the cell surface (Bleijs et al.,
2000). A similar type of mechanism could be acting in neu-
trophils where low affinity interactions with ICAM or fi-
brinogen could promote the clustering of inactive aMb2
and subsequent activation of Akt and ERK signaling path-
ways in the absence of a large degree of ligand binding. In
addition, inhibition was observed, and antiapoptotic sig-
naling pathways activated, in neutrophils stimulated with
fMLP in the presence of immobilized ICAM or fibrinogen
(Fig. 9; ICAM data not shown). This observation is impor-
tant because it indicates that irregardless of the state of
aMb2 activation, binding of natural ligands by b2-integrins
can inhibit spontaneous apoptosis to a high degree.
VIM12, Mn21, and fMLP-mediated inhibition was
blocked by anti-aM Fab (Fig. 2) indicating that ligand en-
gagement by activated aMb2 was necessary to inhibit apop-
tosis. Since these experiments were conducted in suspen-
Figure 7. Fas ligation plus b2-inte-
grin activation or clustering
prevented Akt activation. Cells
were preincubated with or with-
out anti-Fas IgM for 5 min be-
fore incubation with antibodies,
rhICAM-1 beads, or MnCl2 for
20 min. Akt activity was mea-
sured as in Fig. 4. Bars represent
32P incorporated above un-
treated cells (cpm 6 SD; n 5 3).
Similar effects were seen with
TNFa (data not shown).Whitlock et al. aMb2 Regulation of Apoptosis 1317
sion cultures (minimal surface engagement), it is probable
that this inhibition is a result of homotypic neutrophil ag-
gregation (Lynman et al., 1998). VIM12, Mn21, and fMLP
are all capable of stimulating some degree of neutrophil
aggregation (Stöckl et al., 1995; Lynman et al., 1998) lead-
ing to ligand-mediated aMb2 cross-linking. Therefore,
while we distinguish between activation and clustering as
two separate physical states of b2-integrins (Fig. 10), it is
likely that activated aMb2 are present as clusters in the
membrane. Indeed, immunofluorescence confirms that
VIM12 and Mn21 clusters aMb2 (Fig. 3 A; Mn21 data not
shown). Unlike clustering of inactive aMb2, apoptosis sup-
pression mediated by activated aMb2 was unaffected by
MAPK (ERK) inhibition, but was reversed by PI-3K
blockade (Fig. 4 A). The activation of downstream effec-
tors correlated with this, in that activation of Akt, but not
ERK, was seen. It is interesting that activated aMb2 is ca-
pable of inhibiting neutrophil apoptosis in the absence of
ERK activation. This suggests that the activation of PI-3K
pathways alone can, under certain circumstances, compen-
sate for the loss of concomitant MAPK activation. It is
possible that augmented signals from activated aMb2 are
capable of sustained activation of PI-3K pathways. As
mentioned above, Akt remained active for a longer period
Figure 8. Clustering of b2-integrins inhibits Fas-induced apopto-
sis (in the absence of Akt) via continued ERK activation. (A)
Cells were preincubated without or with anti-Fas IgM for 5 min before incubation with 2LPM19c or rhICAM beads for 20 min. ERK ac-
tivity was measured as in Fig. 4. (B) Cells were treated with PD98059 as in Fig. 3, followed by the addition of 2LPM19c or rhICAM-1
beads and anti-Fas IgM. Apoptosis was assessed at 4 h. Bars represents mean percent inhibition 6 SD (n 5 3).
Figure 9. Neutrophil apoptosis is inhibited on fi-
brinogen in a PI-3K and MAPK dependent man-
ner.  111In-labeled neutrophils (6 3 104 cells/ml)
were incubated either in suspension or on fibrino-
gen-coated glass coverslips. After a 4 h incuba-
tion, cells were fixed, nonadherent and adherent
cells were separated and stained with DAPI to
measure apoptosis. PD 98059 (30 mM) and wort-
mannin (100 nM) were added after labeling 15
min before plating. Apoptotic percentages were
calculated as outlined in the Materials and Meth-
ods. Graph represents the percent inhibition of
apoptosis on fibrinogen compared with suspen-
sion culture. Bars represent the mean 6 SD (n 5
5). The significance of reversal of inhibition by
PD98059 and wortmannin was determined by sin-
gle mean comparisons to control percent inhibi-
tion using the Tukey-Kramer test (*P  ,  0.05,
compared with control inhibition; †P , 0.05, com-
pared with fMLP-stimulated inhibition).The Journal of Cell Biology, Volume 151, 2000 1318
upon activation of aMb2 (still high at 30 min). This may al-
low for a greater degree of Akt-mediated mechanisms ca-
pable of maintaining mitochondrial membrane potential
and inhibiting CytC release.
While aMb2 clustering and aMb2 activation induces sur-
vival signals capable of inhibiting spontaneous apoptosis,
differential effects were seen on apoptosis stimulated by
anti-Fas, TNFa, or UV exposure. In this scenario, acti-
vated aMb2 enhanced apoptosis, while inactive, but clus-
tered, aMb2 continued to inhibit apoptosis. A mechanistic
basis for this switch from an antiapoptotic tone to a proap-
optotic one is provided by the data showing that aMb2 me-
diated Akt activation was abrogated in the presence of Fas
ligation and TNFa (Fig. 7; TNFa data not shown). The ab-
sence of this pathway potentially explains why activated
aMb2, which does not activate ERK, no longer inhibits in
the presence of proapoptotic stimuli. In addition, the ef-
fect on mitochondrial membrane potential and CytC re-
lease further supports the notion that Akt may protect the
neutrophil by stabilizing mitochondria; without this mech-
anism clustered, inactive aMb2 no longer confers mito-
chondrial protection and activated aMb2 enhances mito-
chondrial damage (Fig. 6). It is important to note that Fas
ligation alone activated some Akt (Fig. 7). (The possibility
that Fas can activate PI-3K or Akt is not unprecedented;
Datta et al., 1999.) This, therefore, supports that synergis-
tic signals are responsible for turning off Akt. It is likely
that combined signals from Fas and aMb2 can limit the ac-
tivity of PI-3K stimulated pathways either directly, by not
allowing activation and recruitment of molecules involved
in PI-3K activation; or indirectly, by activating molecules
that can inhibit the downstream signaling from PI-3K such
as the inositol phosphatases SH2 domain-containing inosi-
tol 5-phosphate (SHIP) and PTEN (Stambolic et al., 1998;
Liu et al., 1999). SHIP and PTEN are of particular interest
since they have been implicated in integrin signaling (Giu-
rato et al., 1997; Tamura et al., 1999).
Clustering of aMb2 with either 19c or ICAM-1 continued
to inhibit stimulated apoptosis in the apparent absence of
PI-3K/Akt mediated antiapoptotic signals (Fig. 6 A). We
attribute this to aMb2 clustering-mediated activation of
MAPK (MEK/ERK; Figs. 4 and 8). This suggests that a
PI-3K/Akt-independent ERK pathway acts to inhibit anti-
Fas–induced neutrophil apoptosis. This observation ap-
pears to disagree with a previous study from our labora-
tory (Frasch et al., 1998); however, the duration of ERK
activation seen with aMb2 clustering is likely to be signifi-
cantly longer than that seen with other stimuli and could
allow for more antiapoptotic pathway activation. Blocking
ERK activity with PD98059 did not cause aMb2 clustering
induced signals to become proapoptotic (Fig. 8 B) as was
the case with ERK-deficient aMb2 activation (Fig. 6 A).
Activated aMb2 (but not clustered, inactive aMb2) leads to
the production of oxidants that may directly damage mito-
chondria and therefore enhance apoptosis in the absence
of ERK activity (B. Whitlock, unpublished observation).
This is supported by the observation that apoptosis was
significantly enhanced by TNFa on fibrinogen (data not
shown), a scenario known to induce massive oxidant pro-
duction (Nathan et al., 1989).
Our data support an important role for Akt and ERK in
neutrophils; however, downstream targets in these cells re-
main to be identified. Akt can modulate apoptosis through
several potential targets, including the phosphorylation of
proapoptotic family members such as Bad (Datta et al.,
1999). This phosphorylation contributes to an antiapop-
totic balance among Bcl-2 family members and, thus, pre-
vents the alteration of mitochondrial membrane potential
and release of CytC. We have been unable to detect Bad
in human neutrophils (S. Gardai, unpublished observa-
tion) so the significance of this pathway is unclear. How-
ever, a recent report described potential Bad-independent
Akt mechanisms that operate to prevent CytC release
(Kennedy et al., 1999). Other potential targets for acti-
Figure 10. The role of b2-integrin clustering and
activation in neutrophil survival. Signaling model
shows pathways activated upon aMb2 clustering or
activation with arrows indicating stimulatory cas-
cades and gray bars indicating potential points of
inhibition of apoptotic signaling. b2-integrin struc-
tures are modeled after Stewart and Hogg (1996).Whitlock et al. aMb2 Regulation of Apoptosis 1319
vated Akt are the transcription factors CREB and NF-kB
(Datta et al., 1999). Their activation may result in the up-
regulation of antiapoptotic molecules like A1, an NF-kB
inducible gene (Chuang et al., 1998).
Unlike Akt, and with the exception of fMLP stimula-
tion, ERK was only activated by integrin clustering, not
activation. The fact that aMb2 clustering-mediated inhibi-
tion was completely reversed either by inhibition of PI-3K
or MEK (Fig. 4 A) suggests that both Akt and ERK must
be activated and may have common targets, including
those listed above. However, because ERK activity is re-
sponsible for the continued inhibition of stimulated apop-
tosis in the apparent absence of PI-3K/Akt activity and mi-
tochondrial protection, it is likely that other MAPK
targets exist downstream of Bcl-2-family regulation and
CytC release. In support of this, a recent study found that
B-Raf overexpression and constitutive ERK activation in
fibroblasts prevented apoptosis via a mechanism indepen-
dent of PI-3K/Akt, downstream of CytC release, and up-
stream of caspase 3 activation (Erhardt et al., 1999). A
similar role for ERK may be present in neutrophils.
Our data raise the intriguing possibility that repetitive
engagement of active or inactive b2-integrins on circulat-
ing leukocytes as they pass through the microvasculature
could contribute to their in vivo lifespan by delaying their
intrinsic death program. We have earlier shown the need
for cell deformation during microvascular transit (Wor-
then et al., 1989), a circumstance that could provide an
ideal opportunity for transient integrin engagement. The
noncirculating pool of relatively mature granulocytes,
known to be available for immediate release into the cir-
culation, may also be prevented from undergoing cell
death by integrin ligation in the bone marrow (Palframan
et al., 1998). This type of apoptotic control could ulti-
mately dictate the homeostatic levels of circulating leuko-
cytes, as well as contribute to maintenance of cell number
during a systemic immune response.
On the other hand, integrin-mediated cellular survivals
might be counterproductive in the more permanent adhe-
sive environment of an inflammatory reaction, but here, as
we show, the presence of TNFa and other potentially
proapoptotic stimuli (e.g., Fas ligand) would combine to
reverse the protective effects of integrin signaling. Experi-
ments in aM deficient mice support the notion of a likely
role for b2-integrins in the apoptotic progression of elic-
ited inflammatory neutrophils (Coxon et al., 1996). In that
report, the authors speculate that this is due to the ability
of these cells to phagocytose via aMb2, which could, in
turn, stimulate apoptosis. Based on our data, however, we
would propose an alternate interpretation, whereby ex-
travasated neutrophils undergo apoptosis more quickly
due to engagement of activated aMb2 and a death signal
(e.g., TNFa) at the inflammatory site. This enhanced
death could provide, along with apoptotic cell uptake, an
effective mechanism to resolve inflammation. Therefore,
this dual role of integrins in leukocyte apoptosis suggests
that b2-integrins can influence survival throughout the life
of the cell and, therefore, need to be considered in any dis-
cussion of the role of apoptosis in the control of leukocyte
numbers and the resolution of immune responses.
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